Publications ON-BOARD™ ONM-412 ONM-501 Pegsitacianine ONM-501 Brad Good 6/2/24 ONM-501 Brad Good 6/2/24 A Phase 1 Dose-escalation and Expansion Study of an Intratumorally Administered Dual STING Agonist (ONM-501) Alone and in Combination with Cemiplimab Read More Pegsitacianine Brad Good 4/14/24 Pegsitacianine Brad Good 4/14/24 Detection of Residual Peritoneal Metastases Following Cytoreductive Surgery Using Pegsitacianine, a pH-Sensitive Imaging Agent: Final Results from a Phase II Study Read More ONM-412 Brad Good 4/10/24 ONM-412 Brad Good 4/10/24 Preclinical characterization of ONM-412, an ultra-pH sensitive nanoparticle encapsulated IL-12 fusion protein Read More ONM-412 Brad Good 11/3/23 ONM-412 Brad Good 11/3/23 Encapsulation of IL-12 with an ultra pH-sensitive tumor delivery platform improves tolerability and promotes antitumor response in a preclinical model Read More ONM-412 Brad Good 4/18/23 ONM-412 Brad Good 4/18/23 Encapsulation of IL-12 with an ultra pH-sensitive nanoparticle platform improves tolerability and promotes antitumor response in mice Read More ON-BOARD™ Brad Good 4/18/23 ON-BOARD™ Brad Good 4/18/23 Improved Tolerability and Tumor Specific Delivery of a Therapeutic Bispecific T Cell Engager Using a pH-Sensitive Nanoparticle Platform Read More ONM-501 Brad Good 4/18/23 ONM-501 Brad Good 4/18/23 ONM-501, a dual-activating polyvalent STING agonist, enhances tumor retention and demonstrates favorable preclinical safety profile Read More ON-BOARD™ Brad Good 11/14/22 ON-BOARD™ Brad Good 11/14/22 A Clinically Validated pH-Sensitive Nanomedicine Platform for Encapsulating Therapeutic Bispecific T Cell Engagers for Tumor Specific Delivery and Activation Read More ONM-501 Brad Good 11/10/22 ONM-501 Brad Good 11/10/22 A polyvalent STING agonist, exhibits anti-tumor efficacy with increased tumor T-cell infiltration in mice and is well tolerated in rats and non-human primates Read More ONM-501 Brad Good 4/13/22 ONM-501 Brad Good 4/13/22 ONM-501 – A polyvalent STING agonist for oncology immunotherapy Read More ON-BOARD™ Brad Good 4/12/22 ON-BOARD™ Brad Good 4/12/22 Encapsulating therapeutic antibodies for tumor specific activation and delivery using a clinically validated pH-sensitive nanoparticle platform Read More ONM-501 Brad Good 2/8/21 ONM-501 Brad Good 2/8/21 Prolonged activation of innate immune pathways by a polyvalent STING agonist Read More ON-BOARD™ Brad Good 12/9/20 ON-BOARD™ Brad Good 12/9/20 Exploiting nanoscale cooperativity for precision medicine Read More Pegsitacianine Brad Good 6/26/20 Pegsitacianine Brad Good 6/26/20 Exploiting metabolic acidosis in solid cancers using a tumor-agnostic pH-activatable nanoprobe for fluorescence-guided surgery Read More ON-BOARD™ Brad Good 3/1/20 ON-BOARD™ Brad Good 3/1/20 PET Imaging of Occult Tumours by Temporal Integration of Tumour-acidosis Signals from pH-sensitive 64Cu-Labelled Polymers Nat BME, Huang, 2020 314-324 Read More Pegsitacianine Brad Good 6/1/19 Pegsitacianine Brad Good 6/1/19 Image Guided Surgery for Tumor Agnostic Detection of Solid Tumors Using the pH Activated Micellar Imaging Agent ONM-100 Read More ON-BOARD™ Brad Good 5/8/19 ON-BOARD™ Brad Good 5/8/19 Transistor-like Ultra-pH-Sensitive Polymeric Nanoparticles Read More Pegsitacianine Brad Good 8/16/17 Pegsitacianine Brad Good 8/16/17 Investigation of endosome and lysosome biology by ultra pH-sensitive nanoprobes Read More Pegsitacianine Brad Good 12/19/16 Pegsitacianine Brad Good 12/19/16 A transistor-like pH nanoprobe for tumour detection and image-guided surgery Read More ON-BOARD™ Brad Good 11/4/16 ON-BOARD™ Brad Good 11/4/16 Digitization of endocytic pH by hybrid ultra-pH-sensitive nanoprobes at single-organelle resolution Read More Older Posts
ONM-501 Brad Good 6/2/24 ONM-501 Brad Good 6/2/24 A Phase 1 Dose-escalation and Expansion Study of an Intratumorally Administered Dual STING Agonist (ONM-501) Alone and in Combination with Cemiplimab Read More
Pegsitacianine Brad Good 4/14/24 Pegsitacianine Brad Good 4/14/24 Detection of Residual Peritoneal Metastases Following Cytoreductive Surgery Using Pegsitacianine, a pH-Sensitive Imaging Agent: Final Results from a Phase II Study Read More
ONM-412 Brad Good 4/10/24 ONM-412 Brad Good 4/10/24 Preclinical characterization of ONM-412, an ultra-pH sensitive nanoparticle encapsulated IL-12 fusion protein Read More
ONM-412 Brad Good 11/3/23 ONM-412 Brad Good 11/3/23 Encapsulation of IL-12 with an ultra pH-sensitive tumor delivery platform improves tolerability and promotes antitumor response in a preclinical model Read More
ONM-412 Brad Good 4/18/23 ONM-412 Brad Good 4/18/23 Encapsulation of IL-12 with an ultra pH-sensitive nanoparticle platform improves tolerability and promotes antitumor response in mice Read More
ON-BOARD™ Brad Good 4/18/23 ON-BOARD™ Brad Good 4/18/23 Improved Tolerability and Tumor Specific Delivery of a Therapeutic Bispecific T Cell Engager Using a pH-Sensitive Nanoparticle Platform Read More
ONM-501 Brad Good 4/18/23 ONM-501 Brad Good 4/18/23 ONM-501, a dual-activating polyvalent STING agonist, enhances tumor retention and demonstrates favorable preclinical safety profile Read More
ON-BOARD™ Brad Good 11/14/22 ON-BOARD™ Brad Good 11/14/22 A Clinically Validated pH-Sensitive Nanomedicine Platform for Encapsulating Therapeutic Bispecific T Cell Engagers for Tumor Specific Delivery and Activation Read More
ONM-501 Brad Good 11/10/22 ONM-501 Brad Good 11/10/22 A polyvalent STING agonist, exhibits anti-tumor efficacy with increased tumor T-cell infiltration in mice and is well tolerated in rats and non-human primates Read More
ONM-501 Brad Good 4/13/22 ONM-501 Brad Good 4/13/22 ONM-501 – A polyvalent STING agonist for oncology immunotherapy Read More
ON-BOARD™ Brad Good 4/12/22 ON-BOARD™ Brad Good 4/12/22 Encapsulating therapeutic antibodies for tumor specific activation and delivery using a clinically validated pH-sensitive nanoparticle platform Read More
ONM-501 Brad Good 2/8/21 ONM-501 Brad Good 2/8/21 Prolonged activation of innate immune pathways by a polyvalent STING agonist Read More
ON-BOARD™ Brad Good 12/9/20 ON-BOARD™ Brad Good 12/9/20 Exploiting nanoscale cooperativity for precision medicine Read More
Pegsitacianine Brad Good 6/26/20 Pegsitacianine Brad Good 6/26/20 Exploiting metabolic acidosis in solid cancers using a tumor-agnostic pH-activatable nanoprobe for fluorescence-guided surgery Read More
ON-BOARD™ Brad Good 3/1/20 ON-BOARD™ Brad Good 3/1/20 PET Imaging of Occult Tumours by Temporal Integration of Tumour-acidosis Signals from pH-sensitive 64Cu-Labelled Polymers Nat BME, Huang, 2020 314-324 Read More
Pegsitacianine Brad Good 6/1/19 Pegsitacianine Brad Good 6/1/19 Image Guided Surgery for Tumor Agnostic Detection of Solid Tumors Using the pH Activated Micellar Imaging Agent ONM-100 Read More
ON-BOARD™ Brad Good 5/8/19 ON-BOARD™ Brad Good 5/8/19 Transistor-like Ultra-pH-Sensitive Polymeric Nanoparticles Read More
Pegsitacianine Brad Good 8/16/17 Pegsitacianine Brad Good 8/16/17 Investigation of endosome and lysosome biology by ultra pH-sensitive nanoprobes Read More
Pegsitacianine Brad Good 12/19/16 Pegsitacianine Brad Good 12/19/16 A transistor-like pH nanoprobe for tumour detection and image-guided surgery Read More
ON-BOARD™ Brad Good 11/4/16 ON-BOARD™ Brad Good 11/4/16 Digitization of endocytic pH by hybrid ultra-pH-sensitive nanoprobes at single-organelle resolution Read More